Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for KURA

Stock NameKura Oncology Inc
TickerKURA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS50127T1097
LEI5493005QORQTZCZYOP39

Show aggregate KURA holdings

News associated with KURA

Kura Oncology (NASDAQ:KURA) Shares Gap Up After Insider Buying Activity
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $8.01, but opened at $8.62. Kura Oncology shares last traded at $8.36, with a volume of 819,759 shares changing hands. Specifically, CEO Troy Edward Wilson purchased 50,000 shares of […] - 2025-09-11 02:33:48
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz
(RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor conference appearances. Companies like Immutep, Nautilus Biotechnology, Pliant - 2025-09-10 01:36:37
Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.10 Consensus Price Target from Brokerages
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong […] - 2025-09-09 02:46:57
Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to […] - 2025-08-12 03:01:02
Kura Oncology, Inc. (NASDAQ:KURA) Shares Bought by Cwm LLC
Cwm LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 892.8% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 28,353 shares of the company’s stock after acquiring an additional 25,497 shares during the quarter. Cwm LLC’s holdings in […] - 2025-07-28 05:02:47
Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.50 Average PT from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy […] - 2025-07-21 02:45:06
SG Americas Securities LLC Decreases Stake in Kura Oncology, Inc. (NASDAQ:KURA)
SG Americas Securities LLC cut its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 15.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,121 shares of the company’s stock after selling 7,918 shares during the period. SG […] - 2025-06-27 04:20:58
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,050 Shares of Kura Oncology, Inc. (NASDAQ:KURA)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.4% in the 4th quarter, HoldingsChannel reports. The fund owned 131,718 shares of the company’s stock after buying an additional 9,050 shares during the period. UBS AM a distinct […] - 2025-06-10 04:20:48
Hennion & Walsh Asset Management Inc. Has $791,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA)
Hennion & Walsh Asset Management Inc. lowered its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,816 shares of the company’s stock after selling 3,099 shares during the […] - 2025-06-08 05:53:09
JMP Securities Reaffirms “Market Outperform” Rating for Kura Oncology (NASDAQ:KURA)
JMP Securities restated their market outperform rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $28.00 target price on the stock. Other equities research analysts have also issued reports about the stock. Barclays lowered their price target on shares of Kura Oncology […] - 2025-06-05 04:25:02
Man Group plc Takes $163,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)
Man Group plc acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 18,705 shares of the company’s stock, valued at approximately $163,000. Other institutional investors have also recently bought and sold shares of the company. Millennium Management LLC lifted its position […] - 2025-05-29 06:22:57
Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LP
Two Sigma Advisers LP grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 147.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 242,200 shares of the company’s stock after acquiring an additional 144,201 […] - 2025-05-29 05:16:54
Millennium Management LLC Increases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)
Millennium Management LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 180.1% during the fourth quarter, HoldingsChannel reports. The firm owned 2,367,148 shares of the company’s stock after buying an additional 1,521,954 shares during the period. Millennium Management LLC’s holdings in Kura Oncology were worth $20,618,000 at the end of the […] - 2025-05-21 05:46:49
Mizuho Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock Price
Kura Oncology (NASDAQ:KURA – Get Free Report) had its price objective decreased by stock analysts at Mizuho from $32.00 to $30.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s target price indicates a potential upside of 370.22% from the company’s […] - 2025-05-21 05:06:53
BNP Paribas Financial Markets Has $1.43 Million Position in Kura Oncology, Inc. (NASDAQ:KURA)
BNP Paribas Financial Markets boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 969.9% in the fourth quarter, Holdings Channel reports. The firm owned 163,559 shares of the company’s stock after purchasing an additional 148,272 shares during the period. BNP Paribas Financial Markets’ holdings in Kura Oncology were worth $1,425,000 […] - 2025-05-19 04:36:55
Wells Fargo & Company MN Has $305,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA)
Wells Fargo & Company MN grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 48.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,989 shares of the company’s stock after acquiring an additional 11,427 shares […] - 2025-05-07 06:20:47
Kura Oncology, Inc. (NASDAQ:KURA) Shares Purchased by MetLife Investment Management LLC
MetLife Investment Management LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 44,828 shares of the company’s stock after acquiring an additional 2,776 shares during the period. MetLife Investment Management LLC’s holdings in Kura Oncology were worth […] - 2025-05-07 05:28:47
Kura Oncology (NASDAQ:KURA) Given Buy Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $40.00 price objective on the stock. Several other brokerages also recently weighed in on KURA. JMP Securities reaffirmed a “market outperform” rating and set a $28.00 […] - 2025-04-29 04:28:55
Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Corebridge Financial Inc.
Corebridge Financial Inc. reduced its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,050 shares of the company’s stock after selling 2,721 shares during the quarter. Corebridge Financial Inc.’s holdings […] - 2025-04-11 04:54:48
Kura Oncology (NASDAQ:KURA) Given Outperform Rating at Wedbush
Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued to investors on Tuesday,RTT News reports. They currently have a $36.00 price objective on the stock. A number of other equities analysts have also recently weighed in on KURA. UBS Group dropped their price target […] - 2025-04-10 04:54:43
Kura Oncology, Inc. (NASDAQ:KURA) Stock Position Increased by Teacher Retirement System of Texas
Teacher Retirement System of Texas lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 19.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,749 shares of the company’s stock after acquiring an additional 2,285 shares during the quarter. Teacher Retirement System of Texas’ holdings in Kura Oncology were worth […] - 2025-04-03 04:16:48
Financial Comparison: Kura Oncology (NASDAQ:KURA) & Repare Therapeutics (NASDAQ:RPTX)
Kura Oncology (NASDAQ:KURA – Get Free Report) and Repare Therapeutics (NASDAQ:RPTX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations. Profitability This table compares Kura Oncology and […] - 2025-04-03 02:22:47
StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to “Buy”
StockNews.com upgraded shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday morning. KURA has been the subject of a number of other reports. Cantor Fitzgerald raised shares of Kura Oncology to a “strong-buy” rating in a research report on Tuesday, […] - 2025-03-27 05:00:50
Kura Oncology (NASDAQ:KURA) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Kura Oncology (NASDAQ:KURA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. KURA has been the topic of a number of other research reports. Jefferies Financial Group lowered their target price on shares of Kura Oncology from $32.00 to $28.00 and set […] - 2025-03-19 04:52:47
20,331 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by AlphaQuest LLC
AlphaQuest LLC acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,331 shares of the company’s stock, valued at approximately $177,000. Several other large investors have also recently added to […] - 2025-03-17 06:04:56
Rhumbline Advisers Purchases 1,923 Shares of Kura Oncology, Inc. (NASDAQ:KURA)
Rhumbline Advisers boosted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,991 shares of the company’s stock after acquiring an additional 1,923 shares during the period. Rhumbline Advisers’ holdings […] - 2025-03-07 07:20:52
Kura Oncology (NASDAQ:KURA) Raised to “Strong-Buy” at Cantor Fitzgerald
Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports. Several other research firms have also recently commented on KURA. HC Wainwright restated a “buy” rating and set a $40.00 target price on shares of Kura Oncology […] - 2025-03-06 06:20:01
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $27.13
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 04:46:47
Barclays PLC Has $3.23 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)
Barclays PLC boosted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 104.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 165,484 shares of the company’s stock after purchasing an additional 84,563 shares during the period. Barclays PLC’s holdings in Kura […] - 2025-02-11 06:42:48
Jennison Associates LLC Acquires Shares of 71,497 Kura Oncology, Inc. (NASDAQ:KURA)
Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 71,497 shares of the company’s stock, valued at approximately $623,000. Several other large investors also recently added to or reduced their stakes in KURA. Moody Aldrich Partners LLC lifted its […] - 2025-02-08 07:05:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc KURA holdings

DateNumber of KURA Shares HeldBase Market Value of KURA SharesLocal Market Value of KURA SharesChange in KURA Shares HeldChange in KURA Base ValueCurrent Price per KURA Share HeldPrevious Price per KURA Share Held
2025-11-12 (Wednesday)12,655KURA holding decreased by -41USD 135,155KURA holding decreased by -565USD 135,155-41USD -565 USD 10.68 USD 10.69
2025-11-11 (Tuesday)12,696USD 135,720KURA holding increased by 4697USD 135,7200USD 4,697 USD 10.69 USD 10.32
2025-11-10 (Monday)12,696USD 131,023KURA holding increased by 5840USD 131,0230USD 5,840 USD 10.32 USD 9.86003
2025-11-07 (Friday)12,696USD 125,183KURA holding decreased by -3808USD 125,1830USD -3,808 USD 9.86003 USD 10.16
2025-11-06 (Thursday)12,696KURA holding decreased by -41USD 128,991KURA holding increased by 2385USD 128,991-41USD 2,385 USD 10.16 USD 9.94002
2025-11-05 (Wednesday)12,737KURA holding decreased by -410USD 126,606KURA holding decreased by -4338USD 126,606-410USD -4,338 USD 9.94002 USD 9.95999
2025-11-04 (Tuesday)13,147KURA holding decreased by -82USD 130,944KURA holding increased by 1697USD 130,944-82USD 1,697 USD 9.95999 USD 9.76997
2025-11-03 (Monday)13,229KURA holding decreased by -84USD 129,247KURA holding decreased by -7478USD 129,247-84USD -7,478 USD 9.76997 USD 10.27
2025-10-31 (Friday)13,313USD 136,725KURA holding decreased by -2263USD 136,7250USD -2,263 USD 10.27 USD 10.44
2025-10-30 (Thursday)13,313USD 138,988KURA holding increased by 2397USD 138,9880USD 2,397 USD 10.44 USD 10.26
2025-10-29 (Wednesday)13,313USD 136,591KURA holding decreased by -3329USD 136,5910USD -3,329 USD 10.26 USD 10.51
2025-10-28 (Tuesday)13,313KURA holding increased by 123USD 139,920KURA holding decreased by -5698USD 139,920123USD -5,698 USD 10.51 USD 11.04
2025-10-27 (Monday)13,190USD 145,618KURA holding increased by 17675USD 145,6180USD 17,675 USD 11.04 USD 9.7
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of KURA by Blackrock for IE00B3VWM098

Show aggregate share trades of KURA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-4111.31010.610 10.680USD -438 8.51 Loss of -89 on sale
2025-11-06SELL-4110.4129.865 9.920USD -407 8.47 Loss of -59 on sale
2025-11-05SELL-41010.4609.650 9.731USD -3,990 8.47 Loss of -519 on sale
2025-11-04SELL-8210.1708.830 8.964USD -735 8.46 Loss of -42 on sale
2025-11-03SELL-8410.3608.940 9.082USD -763 8.45 Loss of -53 on sale
2025-10-28BUY12310.51011.050 10.996USD 1,353 8.41
2025-10-24SELL-429.7009.710 9.709USD -408 8.39 Loss of -55 on sale
2025-10-15BUY24610.29010.340 10.335USD 2,542 8.33
2025-10-02BUY419.1409.372 9.349USD 383 8.32
2025-09-30BUY828.8509.040 9.021USD 740 8.31
2025-09-11BUY1648.8258.850 8.848USD 1,451 8.30
2025-08-21SELL-417.4407.680 7.656USD -314 8.31 Profit of 27 on sale
2025-07-31BUY1236.0506.285 6.261USD 770 8.33
2025-06-30SELL-825.7705.880 5.869USD -481 8.61 Profit of 225 on sale
2025-06-25SELL-415.8005.970 5.953USD -244 8.67 Profit of 112 on sale
2025-06-20SELL-825.8506.110 6.084USD -499 8.73 Profit of 217 on sale
2025-05-23BUY415.6406.190 6.135USD 252 9.15
2025-05-19SELL-416.2406.295 6.290USD -258 9.25 Profit of 121 on sale
2025-05-15SELL-1235.9505.960 5.959USD -733 9.31 Profit of 412 on sale
2025-05-12SELL-416.0906.325 6.301USD -258 9.40 Profit of 127 on sale
2025-05-09SELL-415.7606.120 6.084USD -249 9.43 Profit of 137 on sale
2025-04-30SELL-416.5606.590 6.587USD -270 9.65 Profit of 125 on sale
2025-04-24SELL-826.4306.494 6.488USD -532 9.78 Profit of 270 on sale
2025-04-17SELL-415.9005.910 5.909USD -242 9.97 Profit of 166 on sale
2025-04-15SELL-1236.0306.110 6.102USD -751 10.06 Profit of 487 on sale
2025-04-14SELL-1235.8505.950 5.940USD -731 10.10 Profit of 512 on sale
2025-04-09SELL-1645.9706.140 6.123USD -1,004 10.25 Profit of 677 on sale
2025-04-07SELL-2945.7606.020 5.994USD -1,762 10.36 Profit of 1,283 on sale
2025-04-04SELL-4205.8906.160 6.133USD -2,576 10.41 Profit of 1,797 on sale
2025-03-31BUY426.6006.950 6.915USD 290 10.55
2025-03-19SELL-847.2707.380 7.369USD -619 10.90 Profit of 296 on sale
2025-03-14SELL-2527.1407.490 7.455USD -1,879 11.05 Profit of 906 on sale
2025-03-13SELL-847.2807.930 7.865USD -661 11.10 Profit of 272 on sale
2025-03-12SELL-1,4287.7107.780 7.773USD -11,100 11.15 Profit of 4,827 on sale
2025-03-07SELL-847.5307.740 7.719USD -648 11.33 Profit of 303 on sale
2025-03-06SELL-1267.7007.720 7.718USD -972 11.38 Profit of 462 on sale
2025-03-03SELL-427.2507.890 7.826USD -329 11.58 Profit of 158 on sale
2025-02-28SELL-34,2727.7107.720 7.719USD -264,546 11.64 Profit of 134,428 on sale
2025-02-26SELL-1317.7708.025 7.999USD -1,048 11.77 Profit of 495 on sale
2025-02-25SELL-3937.8807.960 7.952USD -3,125 11.84 Profit of 1,529 on sale
2025-02-18BUY6557.9858.550 8.494USD 5,563 12.19
2025-02-13BUY1318.2808.500 8.478USD 1,111 12.43
2025-02-12BUY1318.3508.390 8.386USD 1,099 12.51
2025-02-11BUY3938.3408.850 8.799USD 3,458 12.60
2025-02-06BUY1,1798.8209.140 9.108USD 10,738 12.86
2025-01-27BUY1317.9108.260 8.225USD 1,077 13.86
2024-12-30BUY6558.5108.670 8.654USD 5,668 14.53
2024-12-06BUY52410.67011.080 11.039USD 5,784 14.94
2024-12-05BUY13110.71010.920 10.899USD 1,428 15.08
2024-12-04BUY65510.94011.390 11.345USD 7,431 15.23
2024-11-29BUY65511.04011.250 11.229USD 7,355 15.72
2024-11-27BUY52411.17011.440 11.413USD 5,980 16.12
2024-11-26BUY13110.75011.000 10.975USD 1,438 16.36
2024-11-22BUY39310.80011.170 11.133USD 4,375 16.91
2024-11-21BUY26210.06012.240 12.022USD 3,150 17.27
2024-11-20BUY39315.91016.090 16.072USD 6,316 17.35
2024-11-18BUY1,57216.04016.680 16.616USD 26,120 17.51
2024-11-12BUY1,04818.57019.728 19.612USD 20,554 17.44
2024-11-08BUY65517.68017.960 17.932USD 11,745 17.43
2024-11-07BUY1,95017.77018.260 18.211USD 35,511 17.40
2024-11-06BUY26017.84018.580 18.506USD 4,812 17.36
2024-10-31BUY13016.72016.910 16.891USD 2,196 17.43
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of KURA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19234,3990427,53054.8%
2025-09-18192,6770461,70841.7%
2025-09-17227,7480484,32547.0%
2025-09-16207,0490472,16543.9%
2025-09-15220,32259504,33143.7%
2025-09-12257,7000540,78647.7%
2025-09-11407,2061,200815,86349.9%
2025-09-101,435,5332,1052,252,66663.7%
2025-09-09165,7890283,98358.4%
2025-09-08251,9480585,45743.0%
2025-09-05175,7750433,95440.5%
2025-09-04287,87530,282546,30252.7%
2025-09-03332,6840592,29056.2%
2025-09-02336,449130763,24844.1%
2025-08-29265,3240500,47753.0%
2025-08-281,002,33701,540,03165.1%
2025-08-27245,1710535,68845.8%
2025-08-26100,2720269,77737.2%
2025-08-25216,1250430,41150.2%
2025-08-22272,8690977,45027.9%
2025-08-21358,0151898,88239.8%
2025-08-20113,8400512,37922.2%
2025-08-19250,0155,166633,91239.4%
2025-08-18511,1311,0321,191,13042.9%
2025-08-15866,2996,7902,113,20741.0%
2025-08-14126,4300489,95925.8%
2025-08-13254,356600697,34936.5%
2025-08-12426,3092,800816,65952.2%
2025-08-11417,144200889,47846.9%
2025-08-08963,3514,1211,751,42755.0%
2025-08-07166,9550374,93644.5%
2025-08-06218,6702476,66245.9%
2025-08-05226,666802574,95539.4%
2025-08-04223,2590576,65538.7%
2025-08-01126,2160495,11825.5%
2025-07-31120,9200322,60637.5%
2025-07-30158,1810502,32331.5%
2025-07-29132,5761,502553,99423.9%
2025-07-2868,2481,500281,10324.3%
2025-07-25165,9450415,80139.9%
2025-07-24159,69173379,84842.0%
2025-07-23124,3410525,03223.7%
2025-07-22103,797394371,30928.0%
2025-07-21110,3740332,33933.2%
2025-07-18139,8590341,37841.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.